Patents by Inventor Motokuni Mori

Motokuni Mori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anticholesteremic anion exchange resins
    Patent number: 4557930
    Abstract: This invention relates to an anticholesteremic containing a main ingredient of an anion exchange resin which is a copolymer of an imidazole compound modified with a halomethyl oxirane compound and a polyfunctional epoxy resin, and has an imidazolium salt as the functional group in the main chain.
    Type: Grant
    Filed: September 13, 1983
    Date of Patent: December 10, 1985
    Assignees: Mitsubishi Petrochemical Co., Ltd., Mitsubishi Yuka Pharmaceutical Co., Ltd.
    Inventors: Kunio Kihara, Hideo Toda, Motokuni Mori, Koji Morooka
  • Polymeric cholesterol reducing agent having vinylimidazole pendant groups
    Patent number: 4412011
    Abstract: There is provided a cholesterol reducing agent which contains as an active ingredient an anion exchange resin having a functional group of an imidazolium salt represented by the formula: ##STR1## wherein the substituents R.sub.1a through R.sub.4a and X.sup..crclbar. are as defined in the specification and claims.The cholesterol reducing agent according to the present invention has a high selectivity for the adsorption of bile acids and has no bad smell.
    Type: Grant
    Filed: October 13, 1981
    Date of Patent: October 25, 1983
    Assignees: Mitsubishi Petrochemical Co., Ltd., Mitsubishi Yuka Pharmaceutical Co., Ltd.
    Inventors: Kunio Kihara, Hideo Toda, Motokuni Mori, Koji Sato
  • 5,6-Alkylenepyrimidine derivative
    Patent number: 4352928
    Abstract: There are provided a novel compound, i.e., a 2-piperazino-4-substituted-5,6-alkylenepyrimidine derivative represented by the formula: ##STR1## wherein Y, Z and n are defined in the specification and claims, and a pharmaceutically acceptable acid addition salt thereof.The compounds of the present invention show, an anti-inflammatory effect, a blood sugar level lowering effect, a blood platelet aggregation suppressive effect, an anorexigenic action and a Serotonin effect.
    Type: Grant
    Filed: June 16, 1980
    Date of Patent: October 5, 1982
    Assignee: Mitsubishi Yuka Pharmaceutical Co., Ltd.
    Inventors: Hidetoshi Hiranuma, Tetsuo Sekiya, Susumu Mizogami, Motokuni Mori, Mitsuo Hanatsuka, Toshiji Kanayama
  • Novel polysaccharide and hypocholesterol composition containing the same
    Patent number: 4330533
    Abstract: New polysaccharide named M-30-C produced by cultivation of new strain Pseudomonas polysaccharogenes M-30 and having utility as hypocholesterol agents.
    Type: Grant
    Filed: April 24, 1980
    Date of Patent: May 18, 1982
    Assignees: Mitsubishi Petrochemical Co., Ltd., Mitsubishi Yuka Pharmaceutical Co., Ltd.
    Inventors: Yoshihiro Takayama, Fujio Endo, Tsuneo Nozawa, Yoshiro Masuda, Motokuni Mori, Toshiji Kanayama
  • Process for producing a polysaccharide using Pseudomonas polysaccharogenes M-30
    Patent number: 4230800
    Abstract: New polysaccharide named M-30-C produced by cultivation of new strain Pseudomonas polysaccharogenes M-30 and having utility as hypocholesterol agents.
    Type: Grant
    Filed: June 29, 1978
    Date of Patent: October 28, 1980
    Assignees: Mitsubishi Petrochemical Company Limited, Mitsubishi Yuka Pharmaceutical Co., Ltd.
    Inventors: Toshihiro Takayama, Fujio Endo, Tsuneo Nozawa, Yoshiro Masuda, Motokuni Mori, Toshiji Kanayama